|8-KFeb 12, 2:27 PM ET

CIM REAL ESTATE FINANCE TRUST, INC. 8-K

Research Summary

AI-generated summary

Updated

CIM Real Estate Finance Trust, Inc. Amends Revolving Loan; Extends Maturity

What Happened

  • CIM Real Estate Finance Trust, Inc. (the Company) filed an 8‑K on Feb 12, 2026 reporting that its indirect wholly owned subsidiary, CMFT CL Lending Sub AB, LLC (the Borrower), entered into a Second Amendment to the Loan and Security Agreement on Feb 6, 2026 with the lenders, Ally Bank as administrative agent, and U.S. Bank Trust Company, N.A. as collateral custodian.
  • The amendment extends the scheduled revolving period end date from Feb 10, 2026 to Feb 6, 2029, adjusts the termination timing, and lowers the margin over SOFR used to calculate interest.

Key Details

  • Amendment date: Feb 6, 2026; 8‑K filed: Feb 12, 2026.
  • Revolving period end date extended from Feb 10, 2026 to Feb 6, 2029; termination date is now the earlier of (i) two years after the revolving period end or (ii) the date triggered by an event of default.
  • Interest rate change: previously SOFR + 2.875% (plus an additional 2.00% on default) → now SOFR + 2.10% (additional 2.00% on default remains).
  • Related agreements: the Borrower entered an amended and restated collateral management agreement (removing U.S. Bank National Association as document custodian) and an amended and restated fee letter with Ally Bank setting administrative agent compensation. The full Second Amendment is attached as Exhibit 10.1.

Why It Matters

  • For investors, the amendment materially extends the availability of the revolving facility (now through Feb 6, 2029), reducing near‑term refinancing risk for the Borrower and the Company’s consolidated financing structure.
  • The reduced margin over SOFR (from 2.875% to 2.10%) lowers borrowing cost under the facility, which can reduce interest expense if balances are drawn.
  • The amendment preserves default penalty pricing (additional 2.00% in default) and changes custody/fee arrangements, which are operational and cost‑allocation matters to monitor in future disclosures.